RT @CochraneHTN: UPDATED #Cochrane review: insufficient evidence to justify lower than standard blood pressure targets in ppl w hypertensio…
Hypertension. The best available evidence does not support lower blood pressure goals over standard goals. Hipertensión. Cochrane. Mantenga los objetivos clásicos. https://t.co/hKsCr82KW3
RT @CochraneHTN: UPDATED #Cochrane review: insufficient evidence to justify lower than standard blood pressure targets in ppl w hypertensio…
RT @Abraham_RMI: According to this meta-analysis of @CochraneHTN there is no benefit to support strict treatment for patients with hyperten…
RT @CochraneHTN: UPDATED #Cochrane review: insufficient evidence to justify lower than standard blood pressure targets in ppl w hypertensio…
RT @CochraneHTN: UPDATED #Cochrane review: insufficient evidence to justify lower than standard blood pressure targets in ppl w hypertensio…
RT @hswapnil: So the @CochraneHTN published this SR today https://t.co/bPwOrVpwar It suggests there is no advantage to lowering BP in patie…
RT @CochraneHTN: UPDATED #Cochrane review: insufficient evidence to justify lower than standard blood pressure targets in ppl w hypertensio…
RT @AKECassels: The implications of this @CochraneHTN Review are huge: Millions of people are probably taking one, two or three antihypert…
RT @Abraham_RMI: According to this meta-analysis of @CochraneHTN there is no benefit to support strict treatment for patients with hyperten…
RT @Abraham_RMI: According to this meta-analysis of @CochraneHTN there is no benefit to support strict treatment for patients with hyperten…
RT @Abraham_RMI: According to this meta-analysis of @CochraneHTN there is no benefit to support strict treatment for patients with hyperten…
RT @AKECassels: The implications of this @CochraneHTN Review are huge: Millions of people are probably taking one, two or three antihypert…
RT @hswapnil: So the @CochraneHTN published this SR today https://t.co/bPwOrVpwar It suggests there is no advantage to lowering BP in patie…
Reducir el umbral de hipertensión arterial no se asocia a menos mortlidad
Next study should have a third arm of keto-following hypertensives off their meds. My BP dropped from 140/90 to 110/70 without drugs. I've a feeling I'm not the only one who would lower BP by lowering carb intake.
RT @hswapnil: So the @CochraneHTN published this SR today https://t.co/bPwOrVpwar It suggests there is no advantage to lowering BP in patie…
So the @CochraneHTN published this SR today https://t.co/bPwOrVpwar It suggests there is no advantage to lowering BP in patients with cardiovascular dz & HT Warning: this is likely to be a rantorial (h/t @oncology_bg for that term) Part 1:
RT @CochraneHTN: UPDATED #Cochrane review: insufficient evidence to justify lower than standard blood pressure targets in ppl w hypertensio…
RT @Abraham_RMI: According to this meta-analysis of @CochraneHTN there is no benefit to support strict treatment for patients with hyperten…
RT @hswapnil: Will come to this later today Plenty of fodder for discussion. Don't accept the headline conclusion, needless to say! https:…
RT @AKECassels: The implications of this @CochraneHTN Review are huge: Millions of people are probably taking one, two or three antihypert…
RT @AKECassels: The implications of this @CochraneHTN Review are huge: Millions of people are probably taking one, two or three antihypert…
RT @Abraham_RMI: According to this meta-analysis of @CochraneHTN there is no benefit to support strict treatment for patients with hyperten…
RT @Abraham_RMI: According to this meta-analysis of @CochraneHTN there is no benefit to support strict treatment for patients with hyperten…
RT @CochraneHTN: UPDATED #Cochrane review: insufficient evidence to justify lower than standard blood pressure targets in ppl w hypertensio…
RT @AKECassels: The implications of this @CochraneHTN Review are huge: Millions of people are probably taking one, two or three antihypert…
No evidence of a difference in total mortality, serious adverse events, or total cardiovascular events between people with hypertension and cardiovascular disease treated to a lower or to a standard blood pressure target https://t.co/gHik5voKoB
RT @AKECassels: The implications of this @CochraneHTN Review are huge: Millions of people are probably taking one, two or three antihypert…
RT @AKECassels: The implications of this @CochraneHTN Review are huge: Millions of people are probably taking one, two or three antihypert…
RT @AKECassels: The implications of this @CochraneHTN Review are huge: Millions of people are probably taking one, two or three antihypert…
RT @AKECassels: The implications of this @CochraneHTN Review are huge: Millions of people are probably taking one, two or three antihypert…
RT @CochraneHTN: UPDATED #Cochrane review: insufficient evidence to justify lower than standard blood pressure targets in ppl w hypertensio…
Looks like our current Metro-Auckland target for blood pressure 140/90 May still be the way to go despite many guidelines setting lower targets (130/80). Cochrane review finds no benefit from lower blood pressures! https://t.co/7UvF6YoWTf
RT @AKECassels: The implications of this @CochraneHTN Review are huge: Millions of people are probably taking one, two or three antihypert…
Interesting Cochrane review regarding BP lower limits
Lower is not always better. Hypertension is a marker of underlying metabolic disorder. Lowering BP with drugs is a bandaid which fails to address the root cause. Better to treat cause instead.
RT @CochraneHTN: UPDATED #Cochrane review: insufficient evidence to justify lower than standard blood pressure targets in ppl w hypertensio…
RT @AKECassels: The implications of this @CochraneHTN Review are huge: Millions of people are probably taking one, two or three antihypert…
RT @AKECassels: The implications of this @CochraneHTN Review are huge: Millions of people are probably taking one, two or three antihypert…
RT @HeartSisters: I'm now taking 3 different meds to keep lowering borderline high blood pressure! "Evidence is insufficient to justify low…
I'm now taking 3 different meds to keep lowering borderline high blood pressure! "Evidence is insufficient to justify lower blood pressure targets (≤135/85) in people w. hypertension and established cardiovascular disease." https://t.co/lRKsrGO4Cn RT @AKEC
RT @AKECassels: The implications of this @CochraneHTN Review are huge: Millions of people are probably taking one, two or three antihypert…
RT @AKECassels: The implications of this @CochraneHTN Review are huge: Millions of people are probably taking one, two or three antihypert…
#hypertension #overtreatment #HTNEvidence #CochraneEvidence @DTB_Navarre
Interesting! If supported, this could change treatment for a lot of people.
RT @AKECassels: The implications of this @CochraneHTN Review are huge: Millions of people are probably taking one, two or three antihypert…
RT @AKECassels: The implications of this @CochraneHTN Review are huge: Millions of people are probably taking one, two or three antihypert…
RT @AKECassels: The implications of this @CochraneHTN Review are huge: Millions of people are probably taking one, two or three antihypert…
RT @AKECassels: The implications of this @CochraneHTN Review are huge: Millions of people are probably taking one, two or three antihypert…
The implications of this @CochraneHTN Review are huge: Millions of people are probably taking one, two or three antihypertensive drugs to lower their blood pressures for no meaningful benefit. https://t.co/sGt2zOWOrh @Drug_Evidence @MedicineMatters @epaul
RT @CochraneHTN: UPDATED #Cochrane review: insufficient evidence to justify lower than standard blood pressure targets in ppl w hypertensio…
Will come to this later today Plenty of fodder for discussion. Don't accept the headline conclusion, needless to say!
#overtreatment #hypertension @akecassels @eturnermd1 @picardonhealth @amtejani @carole_lunny
UPDATED #Cochrane review: insufficient evidence to justify lower than standard blood pressure targets in ppl w hypertension + CVD https://t.co/WJjmNgk3dF #HTNEvidence #CochraneEvidence #hypertension #HTNEvidence #CochraneEvidence @DrRitaMc @LessIsMoreMed @
UPDATED review: Blood pressure targets for the treatment of people with hypertension and cardiovascular disease: https://t.co/WJjmNgk3dF #HTNEvidence #CochraneEvidence #hypertension @CochraneCanada @CochraneLibrary https://t.co/4Qv1opY1KP